Krebs Biochemicals & Industries Complete Financial Statements
KREBSBIO • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Krebs Biochemicals & Industries (KREBSBIO).
Downloads include all available records across all periods.
For market performance, see the
KREBSBIO stock price today
.
Profitability Ratios
Net Profit Margin
-61.36%
2025 data
EBITDA Margin
-31.82%
2025 data
Operating Margin
-35.00%
2025 data
Return on Assets
-15.98%
2025 data
Balance Sheet Ratios
Current Ratio
0.05
2025 data
Equity Ratio
-86.39%
2025 data
Asset Turnover
0.26
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-36.4%
Year-over-Year
EBITDA Growth
-7.1%
Year-over-Year
Expense Growth
-27.6%
Year-over-Year
Assets Growth
-5.1%
Year-over-Year
Equity Growth
-22.7%
Year-over-Year
Liabilities Growth
-5.1%
Year-over-Year
Operating Cash Flow Growth
-500.0%
Year-over-Year
Investing Cash Flow Growth
+37.5%
Year-over-Year
Financing Cash Flow Growth
+116.7%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28 | 44 | 51 | 53 | 61 | 54 | 34 | 48 | 34 | 3 | 2 | 0 |
| Expenses | 42 | 58 | 59 | 68 | 94 | 71 | 52 | 58 | 41 | 11 | 14 | 5 |
| EBITDA | -15 | -14 | -8 | -15 | -33 | -17 | -18 | -10 | -7 | -8 | -11 | -5 |
| Operating Profit Margin % | -59.00% | -35.00% | -17.00% | -30.00% | -57.00% | -33.00% | -56.00% | -21.00% | -22.00% | -246.00% | -962.00% | 0.00% |
| Depreciation | 7 | 7 | 7 | 7 | 6 | 5 | 5 | 4 | 4 | 4 | 5 | 2 |
| Interest | 7 | 6 | 5 | 3 | 5 | 6 | 6 | 6 | 5 | 4 | 1 | 4 |
| Profit Before Tax | -27 | -27 | -20 | -25 | -45 | -28 | -29 | -20 | -18 | -16 | -16 | -8 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -27 | -27 | -20 | -25 | -45 | -28 | -29 | -20 | -18 | -16 | -16 | -8 |
| Earnings Per Share (₹) | -12.70 | -12.49 | -9.15 | -11.30 | -20.81 | -14.37 | -17.90 | -12.83 | -12.97 | -11.68 | -12.49 | -8.24 |
Related Pages for Krebs Biochemicals & Industries
Additional stock information and data for KREBSBIO
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 169 | 178 | 175 | 190 | 159 | 134 | 142 | 126 | 122 | 116 | 108 |
| Current Assets | 10 | 17 | 16 | 36 | 21 | 19 | 31 | 17 | 13 | 9 | 15 |
| Fixed Assets | 146 | 150 | 147 | 139 | 118 | 105 | 101 | 101 | 102 | 93 | 58 |
| Capital Work in Progress | 3 | 2 | 4 | 8 | 12 | 4 | 4 | 4 | 4 | 11 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 20 | 26 | 24 | 43 | 29 | 24 | 38 | 21 | 16 | 13 | 50 |
| LIABILITIES | |||||||||||
| Total Liabilities | 169 | 178 | 175 | 190 | 159 | 134 | 142 | 126 | 122 | 116 | 108 |
| Current Liabilities | 212 | 236 | 225 | 187 | 154 | 116 | 102 | 101 | 89 | 74 | 61 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | -146 | -119 | -100 | -75 | -43 | -25 | -14 | -18 | 2 | 13 | 18 |
| Share Capital | 22 | 22 | 22 | 22 | 20 | 18 | 17 | 14 | 14 | 13 | 10 |
| Reserves & Surplus | -168 | -141 | -121 | -97 | -67 | -43 | -31 | -32 | -12 | -4 | -14 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -8 | 2 | -25 | -17 | -15 | -36 | 4 | -6 | -11 | -15 | -45 |
| Investing Activities | -5 | -8 | -13 | -23 | -23 | -10 | -4 | -3 | -5 | -4 | -3 |
| Financing Activities | 13 | 6 | 37 | 40 | 38 | 29 | 17 | 9 | 16 | 13 | 54 |
| Net Cash Flow | 0 | 0 | 0 | -1 | 1 | -17 | 17 | 0 | 0 | -6 | 6 |